In response to such concerns, Academia Sinica president Wong Chi-huey issued a statement clarifying that he was chosen by the government as a board director to represent state-owned shares in the company, but received no remuneration and had not received shares in exchange for technology. He declared that his sole aim was to secure a license and cooperation agreement from Genentech in order to develop Taiwan's own new drugs industry as rapidly as possible.
為此，翁啟惠院長特別發表聲明表示，自己受政府委託擔任官股董事，既無薪給，也無技術股票，目的只在爭取授權及合作機會，以儘速建立台灣的新藥產業。